نتایج جستجو برای: prostate treatment

تعداد نتایج: 1473921  

A Shams, M Darabi S Ebrahimi

Background Prostate cancer is the second most common cancers in the world which causing harms and waste cost. Furthermore more prostate treatments are in effective and lead to male infertility. Purpose of this study was to evaluate the role gamma radiation with silver nano particles in treatment of human prostate cancer cell line in vitro. MaterialsAndMethods Human prostate cancer cell line DU1...

Journal: :Medical Journal of Shree Birendra Hospital 2022

Prostate cancer is second most common with frequent metastasis occurring to bone. We report a unique case of soft tissue and bony orbital from carcinoma prostate. The patient presented after defaulting the advised treatment. He responded well radiation therapy lesion regressed completely. Our was diagnosed have an oligo-metastatic non-compliant treatment us proptosis, which later be prostate ca...

Journal: :nephro-urology monthly 0
prathamesh joshi department of nuclear medicine and pet-ct,jksookhosy}umlaondrwwwesskhcgo~vwe, worli, india +98-912266573244, [email protected]; department of nuclear medicine and pet-ct,jksookhosy}umlaondrwwwesskhcgo~vwe, worli, india +98-912266573244, [email protected] vikram lele department of nuclear medicine and pet-ct,jksookhosy}umlaondrwwwesskhcgo~vwe, worli, india +98-912266573244, [email protected]

we report a case of prostatic adenocarcinoma, initially presenting with generalized lymphadenopathy, and mimicking lymphoma on flurodeoxyglucose positron emission tomography/computed tomography (fdg pet/ct). our case suggests that in elderly men presenting with generalized lymphadenopathy, the diagnosis of metastatic prostatic carcinoma should not be overlooked even in the absence of typical ur...

Journal: :OncoReview 2023

Prostate cancer is the most common in men Poland. The choice of treatment method depends on many factors, including stage disease, patient's age, life expectancy, presence comorbidities and general condition patient. Hormone therapy one basic methods prostate treatment, both adjuvant palliative treatment. Castration-resistant an incurable disease. However, introduction new hormonal drugs to sig...

Journal: :nephro-urology monthly 0
mohamadreza nowroozi uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran mohsen ayati uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran erfan amini uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran reza mahdian biotechnology research center, molecular medicine department, pasteur institue of iran, tehran, iran behzad yousefi uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran amir arbab uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran

results a total number of 43 specimens were studied, from which 9 were obtained from patients with metastatic prostate cancer. the expression of five examined genes had no correlation with psa level and gleason score. the expression of amacr decreased in metastatic prostate cancer (p = 0.02). the expression of other genes showed no difference between metastatic and non-metastatic tumors (p > 0....

Journal: :acta medica iranica 0
mostafa hosseini department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. seyed ahmad seyedalinaghi iranian research center for hiv/aids (ircha), tehran university of medical sciences, tehran, iran. mahmoud mahmoudi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. willi mcfarland department of epidemiology and biostatistics, university of california, san francisco, usa.

prostate cancer is a major cause of morbidity and mortality in iran, yet there are few studies examining risk factors specific to the iranian context. we conducted a case-control study to explore risk factors for prostate cancer in mazandaran, iran from 2005 to 2008. the cases were 137 men with clinicopathologically confirmed prostate cancer. controls were 137 neighborhood and age match men wit...

Journal: :archives of medical laboratory sciences 0
leila khalafi professor; departmetn of virology, tarbiat modares university, tehran hosein foudazi seied rabi-mahdavi archives of medical laboratory sciences

best treatment option, although, there is no common consent on optimal therapy for advanced prostate cancer. case presentation: the present study reports a case of 75 year-old man who had a huge heterogeneous soft tissue mass lesion with non-homogeneous enhancement consisted low attenuated foci occupying pelvis cavity and lower abdomen with loss of mesenteric fat and invasion to posterior bladd...

Mestastatic prostate cancer cells (MPCCs) frequently metastasize to bone, which is a “favorite soil” for colonization and proliferation of MPCCs. Prostate cancer bone mestastasis is tightly associated with tumor-induced bone lesions, most commonly caused from the etiological imbalance between osteoblastic bone formation and osteoclastic bone resorption, and from the anti-tumor immune response. ...

Journal: :acta medica iranica 0
gholamreza pourmand department of urology, sina hospital, urology research center, tehran university of medical sciences, tehran, iran. shahram gooran department of urology, sina hospital, urology research center, tehran university of medical sciences, tehran, iran. seyed reza hossieni department of urology, sina hospital, urology research center, tehran university of medical sciences, tehran, iran. fateme guitynavard department of urology, sina hospital, urology research center, tehran university of medical sciences, tehran, iran. majid safavi department of urology, sina hospital, urology research center, tehran university of medical sciences, tehran, iran. amirsina sharifi department of urology, sina hospital, urology research center, tehran university of medical sciences, tehran, iran.

preoperative gleason score (gs) obtained from trans rectal ultra sonography (trus) is the most common grading system to evaluate the appropriate treatment for patients with clinically localized prostate cancer. but this method showed upgraded and downgraded results in comparison to gleason score obtained from radical prostatectomy. the current study aimed to determine clinical or pathological v...

Journal: :iranian journal of radiation research 0
s. r. mahdavi medical physics department of iran university of medical sciences, tehran, iran e. jazayeri gharehbagh department of radiology and radiotherapy technology, school of allied health sciences, tehran university of medical sciences, tehran, iran b. mofid 3radiotherapy department of shahid beheshti university of medical sciences, tehran, iran a. h. jafari research center of biomedical technology and robotics, tehran university of medial sciences, tehran, iran a. r. nikoofar radiotherapy department of iran university of medical sciences, tehran, iran

background: to correct patient positioning errors (setup errors) during prostate cancer treatment using epid and fiducial gold markers, to improve the accuracy of the dose delivery in these patients. materials and methods: fifteen patients with localized prostate carcinoma after implantation of fiducial gold markers in their prostate gland underwent the five-field imrt planning technique. the p...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید